ada glp-1 2025 Highlights: A New Era for Therapies in Obesity and Diabetes ADA '26: Lilly's dominance, Pfizer's

As GLP-1s gained widespread popularity over the past few years, thousands of people began to share their experiences with reduced alcohol cravings on social media, with some even saying the drug completely eliminated their desire to drink

However, its efficacy is substantially compromised in patients with obesity caused by MC4R deficiency, a common monogenic form of obesity

As a mom to four wonderful boys and a few fur babies, her journey into the world of blogging began after making the life-changing decision to stay home and raise her children

And be wary of foods touting themselves as low sugar as theyre often loaded with non-nutritive sweeteners